Eribulin Mesylate-based Therapy in Patients With Advanced HER2-negative Breast Cancer Previously Treated With ADC

NCT07480694 · clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
400
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Fudan University